Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Pre-Eclampsia

rosiglitazone has been researched along with Pre-Eclampsia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Drewlo, S; Grimaldi, B; Kohan-Ghadr, HR1
Drewlo, S; Grimaldi, B; Halari, CD; Kingdom, JC; Kohan-Ghadr, HR; Nandi, P1
Armistead, B; Drewlo, S; Kadam, L; Kingdom, JC; Kohan-Ghadr, HR; McCarthy, FP; Siegwald, E1
Fu, Q; Guan, F; Jiang, M; Lin, J; Liu, L; Zhuang, X1
Allam, HIG; Masri, AAA1
Drewlo, S; Johns, EJ; Kenny, LC; Kingdom, J; McCarthy, FP; Walsh, SK1

Other Studies

6 other study(ies) available for rosiglitazone and Pre-Eclampsia

ArticleYear
The Potential for Placental Activation of PPARγ to Improve the Angiogenic Profile in Preeclampsia.
    Cells, 2022, 11-06, Volume: 11, Issue:21

    Topics: Culture Media, Conditioned; Female; Human Umbilical Vein Endothelial Cells; Humans; Placenta; Placenta Growth Factor; PPAR gamma; Pre-Eclampsia; Pregnancy; Rosiglitazone; Vascular Endothelial Growth Factor Receptor-1

2022
Rosiglitazone-Mediated Activation of PPARγ Restores HO1 Expression in the Human Preeclamptic Placenta.
    Hypertension (Dallas, Tex. : 1979), 2023, Volume: 80, Issue:11

    Topics: Female; Heme Oxygenase-1; Humans; Infant, Newborn; Placenta; PPAR gamma; Pre-Eclampsia; Pregnancy; Rosiglitazone; Trophoblasts

2023
Induction of the PPARγ (Peroxisome Proliferator-Activated Receptor γ)-GCM1 (Glial Cell Missing 1) Syncytialization Axis Reduces sFLT1 (Soluble fms-Like Tyrosine Kinase 1) in the Preeclamptic Placenta.
    Hypertension (Dallas, Tex. : 1979), 2021, Volume: 78, Issue:1

    Topics: Benzamides; Cell Differentiation; DNA-Binding Proteins; Female; Gene Expression; Humans; Placenta; PPAR gamma; Pre-Eclampsia; Pregnancy; Pyridines; RNA Interference; Rosiglitazone; Signal Transduction; Transcription Factors; Trophoblasts; Vascular Endothelial Growth Factor Receptor-1

2021
ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia.
    Cell death & disease, 2017, 09-21, Volume: 8, Issue:9

    Topics: Angiopoietin-Like Protein 4; Cell Movement; Cell Proliferation; Cell Survival; Female; Human Umbilical Vein Endothelial Cells; Humans; Models, Biological; Neoplasm Invasiveness; Neovascularization, Physiologic; PPAR gamma; Pre-Eclampsia; Pregnancy; Promoter Regions, Genetic; Protective Agents; Protein Binding; Rosiglitazone; Thiazolidinediones; Transcription, Genetic; Trophoblasts

2017
The Potential Therapeutic Role of Peroxisome ProliferatorActivated Receptors Agonist in Preeclamptic Pregnant Rats.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:1

    Topics: Animals; Female; Kidney Glomerulus; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; PPAR alpha; Pre-Eclampsia; Pregnancy; Rats; Rosiglitazone; Thiazolidinediones

2018
Peroxisome proliferator-activated receptor-γ as a potential therapeutic target in the treatment of preeclampsia.
    Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:2

    Topics: Animals; Blood Pressure; Female; Metalloporphyrins; PPAR gamma; Pre-Eclampsia; Pregnancy; Protoporphyrins; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2011